< Go Back

Cutting Costs & Delivering Growth While Managing a Multi-Product Pharmaceutical Franchise
New Study Examines Big Data Presence, Utilization across Medical and Commercial Operations in the Pharmaceutical Industry
Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 10 of Consumer Watchdog Campaign Series
Actavis and Durata Therapeutics Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Durata
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Pacira Pharmaceuticals, Inc. and Certain Officers - PCRX
Talyst Exhibits at ASCP Annual Meeting
The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma
Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis
Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting
Evidence presented at the 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID) Supports Individualized Dosing with Hizentra®
Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures
Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses
Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer
Lorcaserin Data to be Presented at The Obesity Society's Annual Scientific Meeting
Mast Therapeutics Reports Third Quarter 2014 Financial Results
AbbVie Reports Third-Quarter 2014 Financial Results
Veloxis announces tentative approval of Envarsus® XR
Report: Stem Cell Technologies Market Growing
Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call
Sildenafil Citrate Market 2014 Analysis for Global and China Regions
E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA™ (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation
Process Validation in the US and EU (Workshop, London)
Game Changing Migraine Medication To Be Available November 2014
Synageva BioPharma Reports Third Quarter 2014 Financial Results
Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16
Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call
Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies
Vermillion Sets Third Quarter 2014 Conference Call for Thursday, November 13, 2014
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache"
Blood Glucose Testing and Diabetes Management
Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition
Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Diffusion Pharmaceuticals to Present at Cavendish Global Health Impact Forum
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan
Mylan Launches Generic Viramune XR®
Bristol-Myers Squibb/Otsuka's Abilify is a Preferred Branded Agent for the Treatment of Schizophrenia, According to Surveyed U.S. Psychiatrists and Payers
PCMA: New NCPA Report Calls for "Lock-In" Pharmacy Program to Fight Medicare Fraud and Abuse
Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China
Chugai licenses ISPRI/OptiMatrix platform from EpiVax for de-risking biologics
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS
AnaMar AB Reports Top-Line Results from Exploratory Phase 2a Study of AMAP102 and Provides Corporate Update
Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014
China Biologic to Report Third Quarter 2014 Financial Results
Protection Against Norovirus by Human-Milk-Oligosaccharides
Molecular Profiles To Launch US Strategic Alliance At AAPS
Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets
CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems

< Prev Next >
PR Newswire - United Business Media